RU2015121771A - Мультивалентная композиция на основе конъюгатов пневмококковый полисахарид-белок - Google Patents
Мультивалентная композиция на основе конъюгатов пневмококковый полисахарид-белок Download PDFInfo
- Publication number
- RU2015121771A RU2015121771A RU2015121771A RU2015121771A RU2015121771A RU 2015121771 A RU2015121771 A RU 2015121771A RU 2015121771 A RU2015121771 A RU 2015121771A RU 2015121771 A RU2015121771 A RU 2015121771A RU 2015121771 A RU2015121771 A RU 2015121771A
- Authority
- RU
- Russia
- Prior art keywords
- immunogenic composition
- multivalent immunogenic
- adjuvant
- composition according
- aluminum
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/09—Lactobacillales, e.g. aerococcus, enterococcus, lactobacillus, lactococcus, streptococcus
- A61K39/092—Streptococcus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/02—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/12—Carboxylic acids; Salts or anhydrides thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/62—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
- A61K47/64—Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent
- A61K47/6415—Toxins or lectins, e.g. clostridial toxins or Pseudomonas exotoxins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/62—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
- A61K47/64—Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent
- A61K47/646—Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent the entire peptide or protein drug conjugate elicits an immune response, e.g. conjugate vaccines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55505—Inorganic adjuvants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
- A61K2039/6031—Proteins
- A61K2039/6037—Bacterial toxins, e.g. diphteria toxoid [DT], tetanus toxoid [TT]
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Inorganic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Virology (AREA)
- Toxicology (AREA)
- Dermatology (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicinal Preparation (AREA)
Claims (14)
1. Мультивалентная иммуногенная композиция, содержащая
13 различных конъюгатов полисахарид-белок вместе с физиологически приемлемой средой,
отличающаяся тем, что каждый из конъюгатов полисахарид-белок содержит капсульный полисахарид от отдельного серотипа Streptococcus pneumoniae, конъюгированный с белком-носителем, и капсульные полисахариды получены от 12 серотипов, выбранных из группы, состоящей из 1, 3, 4, 5, 6А, 6В, 7F, 9V, 14, 18С, 19А, 19F и 23F, и серотипа 22F или 33F.
2. Мультивалентная иммуногенная композиция по п. 1, отличающаяся тем, что белком-носителем является CRM197.
3. Мультивалентная иммуногенная композиция по п. 1, дополнительно содержащая адъювант.
4. Мультивалентная иммуногенная композиция по п. 3, отличающаяся тем, что адъювант представляет собой адъювант на основе алюминия.
5. Мультивалентная иммуногенная композиция по п. 4, отличающаяся тем, что адъювант выбран из группы, состоящей из фосфата алюминия, сульфата алюминия и гидроксида алюминия.
6. Мультивалентная иммуногенная композиция по п. 5, отличающаяся тем, что адъювантом является фосфат алюминия.
7. Фармацевтическая композиция для индукции иммунного ответа на конъюгаты капсульного полисахарида Streptococcus pneumoniae, при этом фармацевтическая композиция содержит иммунологически эффективное количество мультивалентной иммуногенной композиции по любому из пп. 1-6.
8. Фармацевтическая композиция по п. 7, отличающаяся тем, что мультивалентная иммуногенная композиция представляет собой однократную дозу 0,5 мл, составленную с содержанием:
2 мкг полисахарида каждого серотипа, за исключением 6В из расчета 4 мкг;
приблизительно 34 мкг белка-носителя CRM197;
адъюванта, содержащего 0,125 мг элементарного алюминия (0,5 мг фосфата алюминия); и
хлорида натрия, и буфера на основе сукцината натрия в качестве наполнителей.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020120143318A KR20140075201A (ko) | 2012-12-11 | 2012-12-11 | 다가 폐렴구균 다당류-단백질 접합체 조성물 |
KR10-2012-0143318 | 2012-12-11 | ||
PCT/KR2013/011195 WO2014092378A1 (ko) | 2012-12-11 | 2013-12-05 | 다가 폐렴구균 다당류-단백질 접합체 조성물 |
Publications (2)
Publication Number | Publication Date |
---|---|
RU2015121771A true RU2015121771A (ru) | 2017-01-19 |
RU2613148C2 RU2613148C2 (ru) | 2017-03-15 |
Family
ID=50934609
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
RU2015121771A RU2613148C2 (ru) | 2012-12-11 | 2013-12-05 | Мультивалентная композиция на основе конъюгатов пневмококковый полисахарид-белок |
Country Status (16)
Country | Link |
---|---|
US (1) | US20150343076A1 (ru) |
EP (1) | EP2932980B1 (ru) |
JP (1) | JP2016503016A (ru) |
KR (1) | KR20140075201A (ru) |
CN (1) | CN104837504A (ru) |
BR (1) | BR112015013513B1 (ru) |
CA (1) | CA2894532C (ru) |
CO (1) | CO7461130A2 (ru) |
DK (1) | DK2932980T3 (ru) |
ES (1) | ES2881541T3 (ru) |
MX (1) | MX366762B (ru) |
PH (1) | PH12015501270A1 (ru) |
PL (1) | PL2932980T3 (ru) |
PT (1) | PT2932980T (ru) |
RU (1) | RU2613148C2 (ru) |
WO (1) | WO2014092378A1 (ru) |
Families Citing this family (21)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IL308456A (en) | 2005-04-08 | 2024-01-01 | Wyeth Llc | A multivalent pneumomuroral protein-polysaccharide conjugate preparation |
EP3957321A3 (en) | 2014-01-21 | 2022-07-13 | Pfizer Inc. | Streptococcus pneumoniae capsular polysaccharides and conjugates thereof |
US11160855B2 (en) | 2014-01-21 | 2021-11-02 | Pfizer Inc. | Immunogenic compositions comprising conjugated capsular saccharide antigens and uses thereof |
PE20180172A1 (es) | 2015-05-04 | 2018-01-22 | Pfizer | Conjugados proteina-polisacarido de estreptococo grupo b, metodos para producir conjugados, composiciones inmunogenas que comprenden conjugados y sus usos |
US11147863B2 (en) | 2015-06-23 | 2021-10-19 | Biological E Limited | Multivalent pneumococcal conjugate vaccine |
PE20240927A1 (es) * | 2015-07-21 | 2024-04-30 | Pfizer | Composiciones inmunogenas que comprenden antigenos de sacarido capsular conjugados, kits que las comprenden y sus usos |
EP3347042A4 (en) | 2015-09-10 | 2019-02-20 | Inventprise, LLC. | MULTIVALENT CONJUGATES WITH VIRUSUAL PARTICLES |
CN108289944A (zh) * | 2015-10-07 | 2018-07-17 | 勃林格殷格翰动物保健公司 | 多价猪链球菌多糖-蛋白缀合组合物 |
CU24660B1 (es) | 2016-09-30 | 2023-05-11 | Biological E Ltd | Composiciones de vacunas multivalentes que comprenden conjugados de polisacárido-proteína de streptococcus pneumoniae utilizando proteínas portadoras psaa y crm197 |
KR20190103256A (ko) | 2016-12-30 | 2019-09-04 | 수트로박스, 인코포레이티드 | 비자연 아미노산을 갖는 폴리펩타이드-항원 접합체 |
US11951165B2 (en) | 2016-12-30 | 2024-04-09 | Vaxcyte, Inc. | Conjugated vaccine carrier proteins |
EP3589314A4 (en) * | 2017-02-24 | 2021-04-21 | Merck Sharp & Dohme Corp. | INCREASED IMMUNOGENICITY OF STREPTOCOCCUS PNEUMONIAE POLYSACCHARIDE PROTEIN CONJUGATES |
CA3074703A1 (en) | 2017-09-07 | 2019-03-14 | Merck Sharp & Dohme Corp. | Pneumococcal polysaccharides and their use in immunogenic polysaccharide-carrier protein conjugates |
WO2019050816A1 (en) | 2017-09-07 | 2019-03-14 | Merck Sharp & Dohme Corp. | ANTI-PNEUMOCOCCAL POLYSACCHARIDES AND THEIR USE IN IMMUNOGENIC CONJUGATES POLYSACCHARIDE-PROTEIN CARRIER |
CN117982633A (zh) | 2017-12-06 | 2024-05-07 | 默沙东有限责任公司 | 包含肺炎链球菌多糖蛋白缀合物的组合物及其使用方法 |
CN108159408A (zh) * | 2017-12-29 | 2018-06-15 | 云南沃森生物技术股份有限公司 | 一种多价肺炎球菌多糖-蛋白结合物组合物及其制备方法和应用 |
SG11202006388SA (en) | 2018-02-05 | 2020-07-29 | Sanofi Pasteur Inc | Multivalent pneumococcal polysaccharide-protein conjugate composition |
US11951162B2 (en) | 2018-04-18 | 2024-04-09 | Sk Bioscience Co., Ltd. | Streptococcus pneumoniae capsular polysaccharides and immunogenic conjugate thereof |
EA202191638A1 (ru) | 2018-10-12 | 2021-12-27 | Байолоджикал И Лимитед | Мультивалентная вакцина на основе конъюгата пневмококковый полисахарид-белок |
SG11202106541WA (en) | 2018-12-19 | 2021-07-29 | Merck Sharp & Dohme | Compositions comprising streptococcus pneumoniae polysaccharide-protein conjugates and methods of use thereof |
CA3231684A1 (en) | 2021-09-09 | 2023-03-16 | Affinivax, Inc. | Multivalent pneumococcal vaccines |
Family Cites Families (27)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4673574A (en) | 1981-08-31 | 1987-06-16 | Anderson Porter W | Immunogenic conjugates |
US4902506A (en) | 1983-07-05 | 1990-02-20 | The University Of Rochester | Immunogenic conjugates |
US5057540A (en) | 1987-05-29 | 1991-10-15 | Cambridge Biotech Corporation | Saponin adjuvant |
US4912094B1 (en) | 1988-06-29 | 1994-02-15 | Ribi Immunochem Research Inc. | Modified lipopolysaccharides and process of preparation |
HU212924B (en) | 1989-05-25 | 1996-12-30 | Chiron Corp | Adjuvant formulation comprising a submicron oil droplet emulsion |
CA2059693C (en) | 1991-01-28 | 2003-08-19 | Peter J. Kniskern | Polysaccharide antigens from streptococcus pneumoniae |
IL101715A (en) | 1991-05-02 | 2005-06-19 | Amgen Inc | Recombinant dna-derived cholera toxin subunit analogs |
WO1993013302A1 (de) | 1991-12-23 | 1993-07-08 | Michael Zoche | Motor mit einer vorrichtung zur entölung |
EP0616034B1 (en) | 1993-03-05 | 2004-10-20 | Wyeth Holdings Corporation | Plasmid for production of CRM protein and diphtheria toxin |
US6207646B1 (en) | 1994-07-15 | 2001-03-27 | University Of Iowa Research Foundation | Immunostimulatory nucleic acid molecules |
US6113913A (en) | 1998-06-26 | 2000-09-05 | Genvec, Inc. | Recombinant adenovirus |
AU770333B2 (en) | 1998-09-30 | 2004-02-19 | Government Of The United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services, The | Mutant cholera holotoxin as an adjuvant |
WO2000056360A2 (en) * | 1999-03-19 | 2000-09-28 | Smithkline Beecham Biologicals S.A. | Vaccine against antigens from bacteriae |
GB9906437D0 (en) * | 1999-03-19 | 1999-05-12 | Smithkline Beecham Biolog | Vaccine |
GB0108364D0 (en) * | 2001-04-03 | 2001-05-23 | Glaxosmithkline Biolog Sa | Vaccine composition |
EP1946769B1 (en) * | 2000-06-29 | 2012-05-30 | SmithKline Beecham Biologicals S.A. | Multivalent vaccine composition with reduced dose of Haemophilus influenzae type B |
EP1355918B9 (en) | 2000-12-28 | 2012-01-25 | Wyeth LLC | Recombinant protective protein from $i(streptococcus pneumoniae) |
EP2261241A1 (en) | 2001-04-16 | 2010-12-15 | Wyeth Holdings Corporation | Streptococcus pneumoniae open reading frames encoding polypeptide antigens and uses thereof |
JP2004535187A (ja) | 2001-06-07 | 2004-11-25 | ワイス・ホールデイングス・コーポレーシヨン | アジュバントとしてのコレラホロトキシンの突然変異形 |
KR100877258B1 (ko) | 2001-06-07 | 2009-01-12 | 와이어쓰 홀딩스 코포레이션 | 보조제로서 콜레라 홀로톡신의 돌연변이체 형태 |
EP1603950A2 (en) | 2003-03-17 | 2005-12-14 | Wyeth Holdings Corporation | Mutant cholera holotoxin as an adjuvant and an antigen carrier protein |
IL308456A (en) * | 2005-04-08 | 2024-01-01 | Wyeth Llc | A multivalent pneumomuroral protein-polysaccharide conjugate preparation |
EP3020411A1 (en) * | 2005-12-22 | 2016-05-18 | GlaxoSmithKline Biologicals s.a. | Vaccine |
US8808707B1 (en) * | 2006-05-08 | 2014-08-19 | Wyeth Llc | Pneumococcal dosing regimen |
WO2009000825A2 (en) * | 2007-06-26 | 2008-12-31 | Glaxosmithkline Biologicals S.A. | Vaccine comprising streptococcus pneumoniae capsular polysaccharide conjugates |
WO2010125480A1 (en) * | 2009-04-30 | 2010-11-04 | Coley Pharmaceutical Group, Inc. | Pneumococcal vaccine and uses thereof |
TW201136603A (en) * | 2010-02-09 | 2011-11-01 | Merck Sharp & Amp Dohme Corp | 15-valent pneumococcal polysaccharide-protein conjugate vaccine composition |
-
2012
- 2012-12-11 KR KR1020120143318A patent/KR20140075201A/ko not_active IP Right Cessation
-
2013
- 2013-12-05 PL PL13862871T patent/PL2932980T3/pl unknown
- 2013-12-05 CA CA2894532A patent/CA2894532C/en active Active
- 2013-12-05 RU RU2015121771A patent/RU2613148C2/ru active
- 2013-12-05 MX MX2015007301A patent/MX366762B/es active IP Right Grant
- 2013-12-05 EP EP13862871.4A patent/EP2932980B1/en active Active
- 2013-12-05 CN CN201380064973.5A patent/CN104837504A/zh active Pending
- 2013-12-05 WO PCT/KR2013/011195 patent/WO2014092378A1/ko active Application Filing
- 2013-12-05 BR BR112015013513-7A patent/BR112015013513B1/pt active IP Right Grant
- 2013-12-05 PT PT138628714T patent/PT2932980T/pt unknown
- 2013-12-05 JP JP2015547845A patent/JP2016503016A/ja active Pending
- 2013-12-05 DK DK13862871.4T patent/DK2932980T3/da active
- 2013-12-05 ES ES13862871T patent/ES2881541T3/es active Active
- 2013-12-05 US US14/651,046 patent/US20150343076A1/en not_active Abandoned
-
2015
- 2015-06-04 PH PH12015501270A patent/PH12015501270A1/en unknown
- 2015-07-06 CO CO15154485A patent/CO7461130A2/es unknown
Also Published As
Publication number | Publication date |
---|---|
US20150343076A1 (en) | 2015-12-03 |
KR20140075201A (ko) | 2014-06-19 |
MX366762B (es) | 2019-07-23 |
ES2881541T3 (es) | 2021-11-29 |
CA2894532A1 (en) | 2014-06-19 |
DK2932980T3 (da) | 2021-07-19 |
PH12015501270A1 (en) | 2015-08-24 |
BR112015013513B1 (pt) | 2023-02-07 |
PT2932980T (pt) | 2021-07-29 |
BR112015013513A2 (pt) | 2017-07-11 |
CO7461130A2 (es) | 2015-11-30 |
CA2894532C (en) | 2020-07-07 |
JP2016503016A (ja) | 2016-02-01 |
EP2932980A1 (en) | 2015-10-21 |
AU2013360597A1 (en) | 2015-07-02 |
EP2932980B1 (en) | 2021-06-30 |
RU2613148C2 (ru) | 2017-03-15 |
PL2932980T3 (pl) | 2021-11-08 |
WO2014092378A1 (ko) | 2014-06-19 |
EP2932980A4 (en) | 2016-07-06 |
CN104837504A (zh) | 2015-08-12 |
MX2015007301A (es) | 2016-01-20 |
BR112015013513A8 (pt) | 2018-07-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
RU2015121771A (ru) | Мультивалентная композиция на основе конъюгатов пневмококковый полисахарид-белок | |
RU2015100140A (ru) | Поливалентная композиция, содержащая конъюгаты пневмококковый полисахарид-белок | |
RU2012138368A (ru) | 15-валентная вакцинная композиция на основе конъюгата пневмококкового полисахарида с белком | |
HRP20120278T1 (hr) | Polivalentni pripravak konjugata pneumokoknog polisaharida s proteinom | |
PH12015501269B1 (en) | Multivalent pneumococcal polysaccharide-protein conjugate composition | |
PH12019500672A1 (en) | Multivalent pneumococcal vaccine compositions comprising polysachharide-protein conjugates | |
JP2019526621A5 (ru) | ||
IL276230B2 (en) | A multivalent pneumococcal protein-polysaccharide conjugate preparation | |
HRP20231504T1 (hr) | Polisaharidi kapsule iz bakterije streptococcus pneumoniae i njihovi konjugati | |
JP2020533439A5 (ru) | ||
JP2019526620A5 (ru) | ||
EA200801374A1 (ru) | Вакцина | |
MX2013006539A (es) | Formulaciones novedosas que mitigan la agregacion inducida por agitacion de composiciones inmunogenicas. | |
EA201990126A1 (ru) | Поливалентная пневмококковая полисахаридно-белковая конъюгатная композиция | |
RU2022110368A (ru) | Иммуногенные композиции, содержащие конъюгированные капсульные сахаридные антигены, и их применение | |
AR093161A1 (es) | Composicion de conjugados polisacarido-proteina neumococicos multivalente | |
TH128171B (th) | องค์ประกอบวัคซีนคอนจูเกต 15-วาเลนท์ นิวโมคอคคอล โพลีแซคคาไรด์-โปรตีน | |
RU2020112314A (ru) | Пневмококковые полисахариды и их применение в иммуногенных конъюгатах полисахарид-белок-носитель | |
EA201990131A1 (ru) | Поливалентная пневмококковая полисахаридно-белковая конъюгатная композиция | |
TH128171A (th) | องค์ประกอบวัคซีนคอนจูเกต 15-วาเลนท์ นิวโมคอคคอล โพลีแซคคาไรด์-โปรตีน |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PD4A | Correction of name of patent owner | ||
PC41 | Official registration of the transfer of exclusive right |
Effective date: 20180806 |
|
PC41 | Official registration of the transfer of exclusive right |
Effective date: 20181130 |